SanaCurrents on ImmunityBio’s (IBRX) superagonist to treat NMIBC

By |2022-09-19T08:49:18-04:00September 17th, 2022|Tags: |

Immunitybio, Inc. (NASDAQ:IBRX) Probability Sentiment SUMMARY Backed by biotech billionaire Patrick Soon-Shiong, ImmunityBio, Inc. (NASDAQ:IBRX) [...]